Senti Biosciences, Inc.SNTINASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank67
3Y CAGR-11.5%
5Y CAGR+22.9%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
-11.5%/yr
Annual compound
5Y CAGR
+22.9%/yr
Recent deceleration
Percentile
P67
Within normal range
vs 5Y Ago
2.8x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$26.11M+11.0%
2024$23.51M-32.6%
2023$34.87M-7.3%
2022$37.63M+77.1%
2021$21.25M+128.4%
2020$9.30M+26.7%
2019$7.34M-